enter company
enter a search term
select a sector
enter sector
See all agreements of Epitope Inc. (OR)
MODIFIED TRIPLE NET LEASE Lease Preparation Date: September 30, 1999 Lessor: PS Business Parks, LP, A California Limited Partnership Lessee: Epitope, Inc., An ...
Start of preview. BUSINESS PROTECTION AGREEMENT [EXECUTIVES] In consideration of employment by EPITOPE, INC., or its subsidiaries, affiliates, successors or ...
Start of preview. EMPLOYMENT AGREEMENT This Employment Agreement is entered into as of 5/16/99, between William Block ("Employee") and Epitope, Inc., an Oregon ...
... preview. EMPLOYMENT AGREEMENT This Employment Agreement is entered into as of January 19, 1998, between Charles E. Bergeron ("Employee") and Epitope, Inc., an ...
... ("Employee") and Epitope, Inc., an Oregon corporation (the "Company"). 1. SERVICES. 1.1 EMPLOYMENT. ... EPITOPE, INC. /s/ Edward V. Collom, Jr. ...
... of preview. EMPLOYMENT AGREEMENT This Employment Agreement is entered into as of January 24, 2000, between Robert D. Thompson ("Employee") and Epitope, Inc., an ...
EMPLOYMENT AGREEMENT This Employment Agreement is entered into as of January 13, 1998, between J. Richard George, Ph.D. ("Employee") and Epitope, Inc., an ...
... DISCOUNTED NON-PLAN OPTION This Nonqualified Stock Option Agreement for Discounted Non-Plan Option ("Agreement") is executed by and between Epitope, Inc., an ...
... Epitope, Inc. established this Plan as the Epitope, Inc. ... Effective September 29, 2000, in connection with the merger of Epitope, Inc. ...
Start of preview. 9 EPITOPE, INC. AMENDED AND RESTATED 1991 STOCK AWARD ... Epitope, Inc. ("Corporation"), hereby establishes the Epitope, Inc ...
... Confidential Treatment Requested under 17 CFR a7a7 200.80(b)(4) and 240.24b-2(b)( 1) - 2 - 1.13 " Epitope" means a molecular region of an Antigen, which is ...
... For the purpose of this Agreement in the case of: (i) a protein Antigen encoded by a given gene, any antigenic determinants or epitope containing portions of ...
... by Licensee to prevent Respiratory SyncytialVirus under the trademark SYNAGIS and any predecessor or successor product that binds to the same epitope as such ...
... amount than expected, the risks associated with the Company's ability to develop pharmaceutical products using epitopes, the ability of epitope-based products ...
... Page 3 of 5 using epitopes, the ability of epitope-based products to control infectious diseases and cancer, the safety and efficacy of epitope-based products ...
... shall mean any protein (including any glyco- or lipo-protein), carbohydrate, compound or other composition, and any fragment, peptide or epitope thereof, that ...
Privacy Policy Terms of Service